ClinicalTrials.gov
public full text
Public Domain
Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)
The primary objective of this study is to assess the long-term efficacy of psilocybin with respect to use of new antidepressant treatment, hospitalisations for depression, suicidality, and depressive severity rated using the Montgomery and Asberg Depression Rating Scale (MADRS) over a total of 52 weeks (compared across the 1 mg, 10 mg and 25 mg psilocybin groups from COMP 001).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder#993267
- PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL)#1094826
- Psilocybin for Major Depressive Disorder (MDD)#1165210
- Real-World Psilocybin Therapy for Treatment-Resistant Depression: A Retrospective Observational Study.#445989
- Psilocybin in Alcohol Use Disorder With Comorbid Depression#1059843
Record · ID 1093531
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive